I-Mab Biopharma
IMAB
#9317
Rank
HK$0.51 B
Marketcap
HK$6.29
Share price
-5.65%
Change (1 day)
-55.38%
Change (1 year)

EPS for I-Mab Biopharma (IMAB)

EPS in 2020 (TTM): HK$10.59

According to I-Mab Biopharma's latest financial reports the company's current EPS (TTM) is HK$10.68. In 2021 the company made an earnings per share (EPS) of -HK$37.38 a decrease over its 2020 EPS that were of HK$9.60.

EPS history for I-Mab Biopharma from 2017 to 2020

Annual EPS

Year EPS Change
2021-HK$37.38-489.3%
2020HK$9.60-133.67%
2019-HK$28.52179.42%
2018-HK$10.2127.77%
2017-HK$7.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$7.76-172.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$2.09-119.61%๐Ÿ‡บ๐Ÿ‡ธ USA